# Contact Rejuvenation Peptide — Editorial Desk

> Reach the Rejuvenation Peptide editorial desk for citation corrections, regulatory updates, and research-related correspondence about our Skin & Aesthetics peptide digest.

Correspondence on citations, corrections, and peer-reviewed additions to the research record — the most useful things a literature desk can receive.

## Editorial correspondence

Rejuvenation Peptide welcomes correspondence on the research record: a citation that has been quoted inaccurately, a regulatory reference that has gone out of date, or a peer-reviewed study about GHK-Cu or the GLOW blend (or its BPC-157 or TB-500 components) that should be added to the [references page](/references). Corrections that sharpen the accuracy of the numbers are the most useful messages received and are read carefully.

The most actionable notes specify three things: the page they refer to, the exact passage or number in question, and the supporting citation — a DOI or PubMed ID wherever possible. That lets a proposed change be verified against the primary source before anything is updated.

**Editorial mailbox:** editors@rejuvenationpeptide.com

## What this desk cannot do

A few things fall outside what this site can address, so that no message goes unanswered for the wrong reason. Rejuvenation Peptide is a literature digest, not a clinic or a vendor, so we cannot:

- Advise on, recommend, or comment on human use of any peptide discussed here, whether topical or injectable.
- Suggest a dose, concentration, schedule, or route of administration for any individual.
- Diagnose a condition or evaluate whether a specific research finding applies to a specific person.
- Sell, source, recommend, or help locate any compound from any supplier.
- Answer requests from athletes subject to anti-doping rules about using the GLOW blend or its components, given that BPC-157 and TB-500 are prohibited in sport.

Readers seeking guidance on a health condition should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed; the mailbox is monitored intermittently.

---

Peer-reviewed evidence, reported at study strength — an editorial digest of the skin-peptide literature, never a dose and never a product.